U.S. Markets close in 1 hr 6 mins
  • S&P 500

    4,314.06
    -118.93 (-2.68%)
     
  • Dow 30

    33,677.94
    -906.94 (-2.62%)
     
  • Nasdaq

    14,562.87
    -481.10 (-3.20%)
     
  • Russell 2000

    2,156.83
    -80.04 (-3.58%)
     
  • Crude Oil

    70.45
    -1.52 (-2.11%)
     
  • Gold

    1,763.10
    +11.70 (+0.67%)
     
  • Silver

    22.16
    -0.14 (-0.63%)
     
  • EUR/USD

    1.1730
    -0.0001 (-0.0117%)
     
  • 10-Yr Bond

    1.3060
    -0.0640 (-4.67%)
     
  • Vix

    28.34
    +7.53 (+36.18%)
     
  • GBP/USD

    1.3655
    -0.0082 (-0.5995%)
     
  • USD/JPY

    109.3280
    -0.5670 (-0.5159%)
     
  • BTC-USD

    44,590.88
    -3,435.44 (-7.15%)
     
  • CMC Crypto 200

    1,085.53
    -48.86 (-4.31%)
     
  • FTSE 100

    6,903.91
    -59.73 (-0.86%)
     
  • Nikkei 225

    30,500.05
    +176.75 (+0.58%)
     

EU seals deal with Novavax for up to 200 million COVID-19 vaccines

In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BRUSSELS, Aug 4 (Reuters) - The European Commission has approved a supply contract with U.S. firm Novavax for the purchase of up to 200 million COVID-19 vaccines, the European Commission said on Wednesday.

Under the contract, EU states will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses until 2023, once the shot has been approved by the EU drugs regulator, the Commission said. (Reporting by Francesco Guarascio @fraguarascio; Editing by Alison Williams)